1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Colorado >
  6. Caris Life Sciences Acquires Pharmatech

M&A Deal Summary

Caris Life Sciences Acquires Pharmatech

On May 1, 2019, Caris Life Sciences acquired life science company Pharmatech

Acquisition Highlights
  • This is Caris Life Sciences’ 1st transaction in the Life Science sector.
  • This is Caris Life Sciences’ 1st transaction in the United States.
  • This is Caris Life Sciences’ 1st transaction in Colorado.

M&A Deal Summary
Date 2019-05-01
Target Pharmatech
Sector Life Science
Buyer(s) Caris Life Sciences
Deal Type Add-on Acquisition

Target

Pharmatech

Denver, Colorado, United States
Pharmatech, Inc. is an oncology specialized research management organization. Pharmatech solutions overcome inefficiencies in the clinical trial process by eliminating non-enrolling sites and using previously screened patients for biomarker trials. Pharmatech, Inc. was founded in 1987 and is based in Denver, Colorado.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Caris Life Sciences

Irving, Texas, United States
Category Company
Founded 2008
Sector Life Science
Revenue 412M USD (2024)
DESCRIPTION

Caris Life Sciences is a biosciences company focused on developing and delivering innovative molecular diagnostic, prognostic and theranostic services. As an innovative biotechnology company, Caris is actively working to fulfill the promise of precision medicine through transformative platforms to help patients with cancer and other complex diseases. Caris Life Sciences was founded in 2008 and is based in Irving, Texas.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Colorado M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal